Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.
Institute of Life Sciences, Sant'Anna School of Advanced Studies, Pisa, Italy.
JAMA Otolaryngol Head Neck Surg. 2021 Jan 1;147(1):70-76. doi: 10.1001/jamaoto.2020.4148.
Full-thickness tracheal lesions and tracheoesophageal fistulas are severe complications of invasive mechanical ventilation. The incidence of tracheal complications in ventilated patients with coronavirus disease 2019 (COVID-19) is unknown.
To evaluate whether patients with COVID-19 have a higher incidence of full-thickness tracheal lesions and tracheoesophageal fistulas than matched controls and to investigate potential mechanisms.
DESIGN, SETTING, AND PARTICIPANTS: This is a retrospective cohort study in patients admitted to the intensive care unit in a tertiary referral hospital. Among 98 consecutive patients with COVID-19 with severe respiratory failure, 30 underwent prolonged (≥14 days) invasive mechanical ventilation and were included in the COVID-19 group. The control group included 45 patients without COVID-19. Patients with COVID-19 were selected from March 1 to May 31, 2020, while the control group was selected from March 1 to May 31, 2019.
Patients with COVID-19 had severe acute respiratory syndrome coronavirus 2 infection diagnosed by nasopharyngeal/oropharyngeal swabs and were treated according to local therapeutic procedures.
The primary study outcome was the incidence of full-thickness tracheal lesions or tracheoesophageal fistulas in patients with prolonged invasive mechanical ventilation.
The mean (SD) age was 68.8 (9.0) years in the COVID-19 group and 68.5 (14.1) years in the control group (effect size, 0.3; 95% CI, -5.0 to 5.6). Eight (27%) and 15 (33%) women were enrolled in the COVID-19 group and the control group, respectively. Fourteen patients (47%) in the COVID-19 group had full-thickness tracheal lesions (n = 10, 33%) or tracheoesophageal fistulas (n = 4, 13%), while 1 patient (2.2%) in the control group had a full-thickness tracheal lesion (odds ratio, 38.4; 95% CI, 4.7 to 316.9). Clinical and radiological presentations of tracheal lesions were pneumomediastinum (n = 10, 71%), pneumothorax (n = 6, 43%), and/or subcutaneous emphysema (n = 13, 93%).
In this cohort study, almost half of patients with COVID-19 developed full-thickness tracheal lesions and/or tracheoesophageal fistulas after prolonged invasive mechanical ventilation. Attempts to prevent these lesions should be made and quickly recognized when they occur to avoid potentially life-threatening complications in ventilated patients with COVID-19.
全层气管损伤和气管食管瘘是有创机械通气的严重并发症。新冠肺炎(COVID-19)患者气管并发症的发生率尚不清楚。
评估 COVID-19 患者与匹配对照相比,是否有更高的全层气管损伤和气管食管瘘发生率,并探讨潜在的机制。
设计、设置和参与者:这是一项在一家三级转诊医院重症监护病房进行的回顾性队列研究。在 98 例连续的 COVID-19 合并严重呼吸衰竭患者中,30 例行长时间(≥14 天)有创机械通气,并纳入 COVID-19 组。对照组包括 45 例无 COVID-19 的患者。COVID-19 患者于 2020 年 3 月 1 日至 5 月 31 日入选,对照组于 2019 年 3 月 1 日至 5 月 31 日入选。
COVID-19 患者通过鼻咽/口咽拭子诊断为严重急性呼吸综合征冠状病毒 2 感染,并根据当地治疗方案进行治疗。
主要研究结局为长时间有创机械通气患者全层气管损伤或气管食管瘘的发生率。
COVID-19 组患者的平均(SD)年龄为 68.8(9.0)岁,对照组为 68.5(14.1)岁(效应量为 0.3;95%CI,-5.0 至 5.6)。COVID-19 组和对照组分别有 8 名(27%)和 15 名(33%)女性。COVID-19 组有 14 名(47%)患者发生全层气管损伤(n=10,33%)或气管食管瘘(n=4,13%),而对照组仅有 1 名(2.2%)患者发生全层气管损伤(比值比,38.4;95%CI,4.7 至 316.9)。气管损伤的临床表现和影像学表现为纵隔气肿(n=10,71%)、气胸(n=6,43%)和/或皮下气肿(n=13,93%)。
在这项队列研究中,近一半 COVID-19 患者在长时间有创机械通气后发生全层气管损伤和/或气管食管瘘。应尝试预防这些损伤,并在发生时迅速识别,以避免 COVID-19 有创机械通气患者发生潜在危及生命的并发症。